Ticker
SPROCompany Name
SPERO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
---|---|---|---|
6/30/2025 | $ 48.58M | $ 5.93M | 12.2% |
3/31/2025 | $ 44.58M | $ 7.33M | 16.43% |
12/31/2024 | $ 47.98M | $ 7.79M | 16.24% |
9/30/2024 | $ 106.45M | $ 8.29M | 7.78% |
6/30/2024 | $ 118.46M | $ 8.04M | 6.79% |
3/31/2024 | $ 110.98M | $ 7.79M | 7.01% |
12/31/2023 | $ 103.78M | $ 7.93M | 7.64% |
9/30/2023 | $ 77.7M | $ 8.43M | 10.85% |
6/30/2023 | $ 54.23M | $ 8.63M | 15.91% |
3/31/2023 | $ 53.51M | $ 8.09M | 15.12% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for SPERO THERAPEUTICS INC is calculated as follows: SB Comp. [ $ 4.45M ] / Revenues [ $ 11.05M ]
(=) SB Comp % [ 40.28% ]
Minimum
Jun 30, 2024
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 2.99K |
---|---|
min | -3.97% |
max | 8.43% |
average | 1.72% |
median | 1.04% |
std | 1.9% |